diethylcarbamazine has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izumi, T; Koyama, S; Kubo, K; Masubuchi, T; Nagai, S; Nomura, H; Sato, E; Takamizawa, A | 1 |
| de França, ME; de Oliveira, WH; Dos Santos, LA; Gomes, FO; Lós, DB; Peixoto, CA; Rocha, SW; Rodrigues, GB | 1 |
2 other study(ies) available for diethylcarbamazine and transforming growth factor beta
| Article | Year |
|---|---|
Human lung fibroblasts release chemokinetic activity for monocytes constitutively.
Topics: Adult; Antibodies; Cell Line; Chemokine CCL2; Chemokine CCL5; Chemotaxis, Leukocyte; Cycloheximide; Diethylcarbamazine; Fibroblasts; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Kinetics; Lipoxygenase Inhibitors; Lung; Masoprocol; Monocytes; Platelet Activating Factor; Receptors, Leukotriene B4; T-Lymphocytes; Time Factors; Transforming Growth Factor beta; Trypsin | 1998 |
Diethylcarbamazine: possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Collagen; Cyclooxygenase 2; Cytokines; Cytoprotection; Diethylcarbamazine; Inflammation Mediators; Lipids; Liver; Liver Cirrhosis, Alcoholic; Male; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide Synthase Type II; Signal Transduction; Transforming Growth Factor beta | 2015 |